A colleague and friend of mine wrote this about the drug, lecanemab (Leqembi), a drug I have not been supportive of either. I’m tired of pharmaceutical companies and many members of the medical community focusing on drugs and a potential cure, instead of care. Risk reduction has rightly become a major focus, which of course…